Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Myeloid 1Dermatologic 1

Conditions

Melanoma 71Skin Neoplasms 16Carcinoma, Basal Cell 15Lymphoma, T-Cell, Cutaneous 12Neoplasms 9Keratosis, Actinic 7Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 6Carcinoma, Squamous Cell 6Carcinoma, Merkel Cell 6Mycosis Fungoides 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Breast Neoplasms 5Uveal Melanoma 4Sezary Syndrome 4Neoplasm Metastasis 4Uterine Cervical Neoplasms 3Sarcoma 3Endometrial Neoplasms 3Urogenital Neoplasms 2Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Testicular Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Immune System Diseases × Dermatologic × Clear all
NCT07192471 2026-04-20

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Kyowa Kirin Co., Ltd.

Phase 1 Not yet recruiting
72 enrolled
DermatologicLymphoid

Immune System Diseases, Lymphoma, Mycosis Fungoides, Neoplasms, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡